348599-88-2

Basic information

• Product Name: 2-oxo-2-(p-tolyl)ethyl 3-(benzamido)benzoate
• Synonyms: 2-oxo-2-(p-tolyl)ethyl 3-(benzamido)benzoate
• CAS NO: 348599-88-2
• Molecular Weight: 373.408
• Mol File: 348599-88-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-oxo-2-(p-tolyl)ethyl 3-(benzamido)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-oxo-2-(p-tolyl)ethyl 3-(benzamido)benzoate(348599-88-2)
• EPA Substance Registry System: 2-oxo-2-(p-tolyl)ethyl 3-(benzamido)benzoate(348599-88-2)

Safety Data

• Hazardous Substances Data: 348599-88-2(Hazardous Substances Data)

Upstream product

• 587-54-2 3-benzamidobenzoic acid 
• 619-41-0 4-(bromoacetyl)toluene 
• 99-05-8 meta-aminobenzoic acid 
• 4518-10-9 Methyl 3-aminobenzoate 
• 39799-70-7 3-benzoylamino-benzoic acid methyl ester 

Relevant articles and documents

PHARMACEUTICAL COMPOSITION FOR INHIBITING THE TRANSCRIPTION FACTOR INDUCIBLE BY HYPOXIA, MODULATORS OF PATHOLOGICAL PROCESSES OF ANGIOGENESIS, ONCOGENESIS, INFLAMMATION, APOPTOSIS, AND CELLULAR THERAPY

The present invention is included in the field of pharmacology and medical chemistry and relates to novel molecules represented by general formula (I), especially the one called FM19G11, as well as to pharmaceutical compositions containing them. Said pharmacologically optimized compositions are capable of modulating and/or inhibiting the transcription of genes modulated by the hypoxia-inducible transcription factor (HIF) and which are directly and/or indirectly involved in pathological processes related to cancer, inflammation, tissue repair, stem cell differentiation and regenerative therapy. The present invention also relates to a method for the synthesis of said molecules (I) and to the use thereof in the manufacture of a medicament for the treatment of the mentioned pathological processes.